Literature DB >> 16520860

Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis.

Simona L Bar1, Elizabeth Swiggum, Lynn Straatman, Andrew Ignaszewski.   

Abstract

In addition to its importance in clinical assessment, N-terminal pro-brain natriuretic peptide (NT pro-BNP) is a valuable marker for evaluation of treatment and prognosis of heart failure. However, there are situations where NT pro-BNP is not related to myocardial dysfunction. Two cases of sepsis with markedly elevated NT pro-BNP levels that are not indicative of depressed myocardial function are described.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16520860      PMCID： PMC2528926          DOI： 10.1016/s0828-282x(06)70908-4

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


  39 in total

Review 1.  Effects of nitric oxide in septic shock.

Authors:  J L Vincent; H Zhang; C Szabo; J C Preiser
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

Review 2.  Optimal management of septic shock. Rapid recognition and institution of therapy are crucial.

Authors:  Stephen J Fitch; James R Gossage
Journal:  Postgrad Med       Date:  2002-03       Impact factor: 3.840

3.  More 'malignant' than cancer? Five-year survival following a first admission for heart failure.

Authors:  S Stewart; K MacIntyre; D J Hole; S Capewell; J J McMurray
Journal:  Eur J Heart Fail       Date:  2001-06       Impact factor: 15.534

Review 4.  The B-type natriuretic peptide assay: a rapid test for heart failure.

Authors:  W Frank Peacock
Journal:  Cleve Clin J Med       Date:  2002-03       Impact factor: 2.321

5.  Left ventricular diastolic function in sepsis.

Authors:  S M Jafri; S Lavine; B E Field; M T Bahorozian; R W Carlson
Journal:  Crit Care Med       Date:  1990-07       Impact factor: 7.598

6.  Plasma atrial natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction.

Authors:  Rochus Witthaut; Christian Busch; Peter Fraunberger; Autar Walli; Dietrich Seidel; Günter Pilz; Ralph Stuttmann; Norbert Speichermann; Ljifane Verner; Karl Werdan
Journal:  Intensive Care Med       Date:  2003-08-12       Impact factor: 17.440

7.  B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure.

Authors:  Pascal de Groote; Joël Dagorn; Benoit Soudan; Nicolas Lamblin; Eugene McFadden; Christophe Bauters
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

8.  NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function.

Authors:  M Bay; V Kirk; J Parner; C Hassager; H Nielsen; K Krogsgaard; J Trawinski; S Boesgaard; J Aldershvile
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

9.  Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.

Authors:  A Kumar; V Thota; L Dee; J Olson; E Uretz; J E Parrillo
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  Marked elevations in N-terminal brain natriuretic peptide levels in septic shock.

Authors:  Gerald Chua; Lee Kang-Hoe
Journal:  Crit Care       Date:  2004-06-15       Impact factor: 9.097
View more
  6 in total

1.  Elevated N-terminal pro-brain natriuretic peptide in Mycobacterium tuberculosis pulmonary infection without myocardial dysfunction.

Authors:  Simona L Bar; Naser Sayeh; Andrew P Ignaszewski
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

Review 2.  Myocarditis in the Setting of Cancer Therapeutics: Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology

Authors:  Marc P Bonaca; Benjamin A Olenchock; Joe-Elie Salem; Stephen D Wiviott; Stephane Ederhy; Ariel Cohen; Garrick C Stewart; Toni K Choueiri; Marcelo Di Carli; Yves Allenbach; Dharam J Kumbhani; Lucie Heinzerling; Laleh Amiri-Kordestani; Alexander R Lyon; Paaladinesh Thavendiranathan; Robert Padera; Andrew Lichtman; Peter P Liu; Douglas B Johnson; Javid Moslehi
Journal:  Circulation       Date:  2019-07-02       Impact factor: 29.690

3.  Prognosis Implication of N-Terminal Pro-B-Type Natriuretic Peptide in Adult Patients With Acute Myocarditis.

Authors:  Yan Zhao; Naqiang Lyu; Wei Zhang; Huiqiong Tan; Qi Jin; Aimin Dang
Journal:  Front Cardiovasc Med       Date:  2022-03-30

4.  Future studies should consider multiple predisposing conditions in predicting weaning failure from mechanical ventilation in patients after cardiac surgery.

Authors:  Mehmet Aydogan; Sevket Balta; Ugur Kucuk; Sait Demirkol; Murat Unlu; Seyfettin Gumus
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

5.  Cardiopulmonary involvement in Puumala hantavirus infection.

Authors:  Johan Rasmuson; Per Lindqvist; Karen Sörensen; Magnus Hedström; Anders Blomberg; Clas Ahlm
Journal:  BMC Infect Dis       Date:  2013-10-28       Impact factor: 3.090

6.  Can NT-pro BNP Levels Predict Prognosis of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease in the Intensive Care Unit?

Authors:  Özlem Ediboğlu; Cenk Kıraklı
Journal:  Balkan Med J       Date:  2018-07-03       Impact factor: 2.021
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.